XML 26 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 10 - Income Taxes
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
NOTE
10:
     INCOME TAXES
 
The provision for income taxes includes the following:
 
   
Nine Months Ended September 30,
 
   
2018
   
2017
 
                 
Current:
               
Federal
  $
---
    $
1,195,528
 
State
   
---
     
11,580
 
Total Current Provision
   
 
     
1,207,108
 
Deferred:
               
Federal
  $
(315,922
)   $
559,123
 
State
   
----
     
----
 
Total deferred
   
(315,922
)    
559,123
 
Income tax (benefit)/expense
  $
(315,922
)   $
1,766,231
 
 
 
Tax Rate Reconciliation 
 
The reconciliation between the Company’s effective tax rate on income from continuing operations and the statutory rate is as follows:
 
   
Nine Months Ended
 
   
September 30,
 
   
2018
   
2017
 
Income tax (benefit)/expense at federal statutory rate [21%-2018; 34%-2017]
  $
(652,837
)   $
2,075,004
 
Change in other accruals
   
45,540
     
90,781
 
Difference between tax and book depreciation
   
89,558
     
(201,847
)
Stock-based compensation
   
201,817
     
(197,707
)
Income tax (benefit)/expense
  $
(315,922
)   $
1,766,231
 
  
 
The Company’s foreign entity, CVD Tantaline ApS, has incurred losses since its inception in
December 2016,
which would have provided a deferred tax asset of approximately
$303,000
at
September 30, 2018
and
$190,000
at
December 31, 2017,
based on the standard corporate tax rate of
22%
in Denmark. However, sufficient uncertainty exists as to the realizability of these assets such that a full valuation allowance is necessary.